Ann: Preliminary Final Report, page-24

Extremely saddened and disappointing to see long term shareholder started selling now.

Share price is 4 years low today, doesn’t look like it’s going to stop soon.

I understand it’s a bear market and sector is struggling but in my opinion, Company has failed to provide proper market updates (or strategy) on future direction on R&D projects, reimbursement in US, new clinical trials work and delivering on significant returns in revenue.

Note: I am not here to to down ramp the Company or target Directors/ Management or any other agenda.

All in my opinion and research.